Doximity Inc
NYSE:DOCS
Doximity Inc
NYSE:DOCS
Price:
23.76 USD
-0.5%
Market Closed
Updated:
May 10, 2024
Section:
Relative Value
The Relative Value of one
DOCS
stock under the Base Case scenario is
23.61
USD.
Compared to the current market price of 23.76 USD,
Doximity Inc
is
Overvalued by 1%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DOCS
Relative Value
Base Case
23.61
USD
Overvaluation 1%
Valuation Multiples
Multiples Across Competitors
DOCS Competitors Multiples
Doximity Inc Competitors
Doximity Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9.4 | 32.1 | 21.4 | 22.8 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.9B USD | 13.9 | 62.5 | 62.5 | 67.2 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.2B AUD | 83.7 | 175.6 | 120.8 | 120.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.9 | 24.7 | 12.9 | 14.5 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
5.2B USD | 8.2 | -243.7 | -125.4 | -116.6 | |
| SE |
|
Sectra AB
STO:SECT B
|
43.5B SEK | 26.9 | 102.4 | -67.4 | -67.4 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.6 | 25.5 | 271.5 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 11.7 | -324 | 264.4 | 4 233.4 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.7B USD | 3.6 | -308 | 32.8 | -107.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
